Company Filing History:
1 out of 9 
1 out of 11 
Years Active: 2021
Title: Edgar Davidson: Innovator in Filovirus Research
Introduction
Edgar Davidson is a notable inventor based in Philadelphia, PA (US). He has made significant contributions to the field of virology, particularly in the study of filoviruses. His innovative work has led to advancements in vaccine development and immunogenicity.
Latest Patents
Davidson holds a patent for "Modified ebolavirus glycoproteins comprising mutations in the head and base domains that increase antibody cross-reactivity." This patent outlines methods for incorporating specific substitutions into filovirus glycoproteins to enhance immunogenicity and broaden the protective immune response against various filovirus members. Additionally, the patent includes mutant filovirus glycoproteins that comprise these substitutions.
Career Highlights
Throughout his career, Davidson has worked with several prominent companies in the biotechnology sector. He has been associated with Integrated Biotherapeutics, Inc. and Integral Molecular, Inc., where he has contributed to research and development efforts aimed at combating viral infections.
Collaborations
Davidson has collaborated with notable colleagues, including Mohammad Javad Aman and Katie A Howell. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his research.
Conclusion
Edgar Davidson's work in the field of filovirus research exemplifies the importance of innovation in addressing global health challenges. His contributions continue to pave the way for advancements in vaccine development and immunology.